best injection site for semaglutide for weight loss An Advanced Guide to Sites & Rotation Strategy Where and how to inject

Why the caveats: Most human data is observational, not randomized controlled trials designed to prove prevents dementia. So far, we cannot definitively say GLP-1 RAs prevent Alzheimers

In todays newsletter: A new study shows that people dont just regain weight after stopping GLP-1 drugs, they see other positive health markers reverse leading to questions about long-term impacts and solutions

Lemme does not contain corn syrup, synthetic colors, or sugar alcohols

The foundation is still being read

Glucagon-like peptide-1 (GLP-1) receptor agonists were touted as breakthrough drugsin 2023 and their popularity has soared since. More than 4 million items of tirzepatide and semaglutide were dispensed on the NHS in England in 2025/20261, while around2.5 million people each monthaccessed GLP-1s privately at the end of 2025, according to James Kingsland, chair of []

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), widely used for metabolic disorders, have emerged as promising candidates for a range of neuropsychiatric conditions due to their broad neurobiological effects